SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,816,910 | -52.9% | 4,696,415 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $5,974,687 | +2.2% | 4,595,913 | +38.3% | 0.00% | 0.0% |
| Q1 2023 | $5,848,392 | +19.6% | 3,322,950 | +113.4% | 0.00% | 0.0% |
| Q4 2022 | $4,890,066 | +70.8% | 1,557,346 | +166.5% | 0.00% | – |
| Q3 2022 | $2,863,000 | -12.2% | 584,355 | -25.8% | 0.00% | -100.0% |
| Q2 2022 | $3,261,000 | -19.6% | 787,903 | +12.9% | 0.00% | 0.0% |
| Q1 2022 | $4,055,000 | -49.2% | 697,808 | -34.4% | 0.00% | 0.0% |
| Q4 2021 | $7,979,000 | +12.3% | 1,063,916 | +35.0% | 0.00% | -50.0% |
| Q3 2021 | $7,103,000 | -51.7% | 788,310 | -35.9% | 0.00% | -33.3% |
| Q2 2021 | $14,710,000 | -34.9% | 1,228,869 | -31.9% | 0.00% | -40.0% |
| Q1 2021 | $22,606,000 | +18.4% | 1,804,223 | +47.5% | 0.01% | 0.0% |
| Q4 2020 | $19,091,000 | +4.8% | 1,223,377 | -36.6% | 0.01% | -16.7% |
| Q3 2020 | $18,221,000 | +104.3% | 1,928,150 | +93.7% | 0.01% | +100.0% |
| Q2 2020 | $8,920,000 | -35.0% | 995,456 | -53.8% | 0.00% | -50.0% |
| Q1 2020 | $13,723,000 | +23.6% | 2,154,419 | +62.4% | 0.01% | 0.0% |
| Q4 2019 | $11,104,000 | -51.0% | 1,326,619 | -47.0% | 0.01% | -45.5% |
| Q3 2019 | $22,671,000 | -11.6% | 2,505,115 | +5.2% | 0.01% | 0.0% |
| Q2 2019 | $25,656,000 | +260.1% | 2,382,182 | +219.0% | 0.01% | +266.7% |
| Q1 2019 | $7,124,000 | -25.6% | 746,692 | -10.5% | 0.00% | -40.0% |
| Q4 2018 | $9,575,000 | -51.5% | 834,037 | -28.3% | 0.01% | -44.4% |
| Q3 2018 | $19,728,000 | +105.5% | 1,163,961 | +72.2% | 0.01% | +80.0% |
| Q2 2018 | $9,600,000 | -7.3% | 676,053 | +24.0% | 0.01% | 0.0% |
| Q1 2018 | $10,361,000 | +17.9% | 545,290 | +1.7% | 0.01% | 0.0% |
| Q4 2017 | $8,791,000 | +18.7% | 536,048 | +8.6% | 0.01% | 0.0% |
| Q3 2017 | $7,404,000 | -41.7% | 493,595 | -65.8% | 0.01% | -50.0% |
| Q2 2017 | $12,692,000 | +2872.4% | 1,442,301 | +1654.7% | 0.01% | – |
| Q1 2017 | $427,000 | -37.7% | 82,198 | -63.4% | 0.00% | – |
| Q4 2016 | $685,000 | +30.0% | 224,600 | +97.5% | 0.00% | – |
| Q3 2016 | $527,000 | +584.4% | 113,735 | +797.1% | 0.00% | – |
| Q1 2016 | $77,000 | +600.0% | 12,678 | +929.9% | 0.00% | – |
| Q4 2015 | $11,000 | -94.9% | 1,231 | -96.8% | 0.00% | – |
| Q3 2015 | $217,000 | -78.4% | 38,394 | -40.0% | 0.00% | -100.0% |
| Q1 2015 | $1,003,000 | -60.1% | 64,010 | -61.3% | 0.00% | -50.0% |
| Q4 2014 | $2,514,000 | +63.4% | 165,282 | +15.8% | 0.00% | 0.0% |
| Q3 2014 | $1,539,000 | -40.2% | 142,729 | -15.4% | 0.00% | -33.3% |
| Q2 2014 | $2,575,000 | +113.2% | 168,693 | +152.6% | 0.00% | +200.0% |
| Q1 2014 | $1,208,000 | +23.1% | 66,795 | -5.5% | 0.00% | 0.0% |
| Q4 2013 | $981,000 | +654.6% | 70,682 | +469.7% | 0.00% | – |
| Q3 2013 | $130,000 | +68.8% | 12,406 | +25.9% | 0.00% | – |
| Q2 2013 | $77,000 | – | 9,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |